Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide and inflammation.

Giuseppe Cirino1, Eleonora Distrutti, John L Wallace

  • 1Department of Experimental Pharmacology, Università di Napoli-Federico II, Napoli, Italy. cirino@unina.it

Inflammation & Allergy Drug Targets
|April 15, 2006
PubMed
Summary

Nitric oxide (NO) plays a complex role in inflammation, acting as both anti-inflammatory and pro-inflammatory. Novel nitric oxide-releasing non-steroidal anti-inflammatory drugs (NO-NSAIDs) show promise for future inflammation therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy.

Biochemistry and biophysics reports·2026
Same author

Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancer.

Translational oncology·2026
Same author

Eosinophilic Esophagitis and Lymphocytic Esophagitis: Convergent Symptoms, Divergent Biology.

Recent advances in inflammation & allergy drug discovery·2026
Same author

Hydrogen sulfide generated by cystathionine gamma lyase inhibits lysyl oxidase and protects against calcific tendinopathy.

Journal of orthopaedic translation·2026
Same author

A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis.

Gut microbes·2026
Same author

Secondary bile acids as immune and metabolic mediators.

Trends in immunology·2026

Area of Science:

  • Immunology
  • Pharmacology
  • Biochemistry

Background:

  • Nitric oxide (NO) significantly modulates various cells and immunological parameters in inflammation.
  • The dual role of NO as both anti-inflammatory and pro-inflammatory complicates its therapeutic classification.
  • Previous drug development strategies targeting NO have been hindered by its complex pathophysiology.

Purpose of the Study:

  • To explore the multifaceted role of nitric oxide (NO) in inflammatory processes.
  • To review the challenges in developing NO-based anti-inflammatory drugs.
  • To highlight emerging therapeutic strategies involving NO modulation for inflammation.

Main Methods:

  • Review of pre-clinical studies on nitric oxide's involvement in inflammation.

Related Experiment Videos

  • Analysis of immunological parameters affected by NO.
  • Evaluation of novel therapeutic approaches, including gene activation and NO-releasing compounds.

    • Main Results:

    • Nitric oxide (NO) exhibits complex regulatory effects, not fitting a simple pro- or anti-inflammatory definition.
    • The dual nature of NO has impeded the development of targeted anti-inflammatory drugs.
    • Emerging strategies focus on increasing endogenous NO production and utilizing NO-releasing compounds.

    Conclusions:

    • Nitric oxide's (NO) role in inflammation is complex and context-dependent.
    • New therapeutic avenues involve enhancing endogenous NO and developing NO-releasing agents.
    • Nitric oxide-releasing non-steroidal anti-inflammatory drugs (NO-NSAIDs) represent a promising advancement, with compounds entering Phase 2 clinical trials.